Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

Kimberly McClinch(Icahn School of Medicine at Mount Sinai), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Janna Kiselar(University School), Sudeh Izadmehr(Icahn School of Medicine at Mount Sinai), Daniel McQuaid(Icahn School of Medicine at Mount Sinai), Max Cooper(Brighton and Sussex Medical School), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), Danica Wiredja(Case Western Reserve University), Jaya Sangodkar(Pediatrics and Genetics), David Callejas(Case Western Reserve University), Cynthia C.T. Sprenger(University of Washington), Divya Hoon(Icahn School of Medicine at Mount Sinai), Agnes Stachnik(Icahn School of Medicine at Mount Sinai), Rita A. Avelar(University of Michigan), David B. Kastrinsky(Icahn School of Medicine at Mount Sinai), Goutham Narla(Pediatrics and Genetics), Daniela Schlatzer(Case Western Reserve University), Stephen R. Plymate(VA Puget Sound Health Care System), David L. Brautigan(Brown University), Alice C. Levine(Icahn School of Medicine at Mount Sinai), William Oh(Princeton University), Analisa DiFeo(University of Michigan), Nilesh Zaware(Icahn School of Medicine at Mount Sinai), Rosalie C. Sears(Portland State University), Abbey Perl(Northwestern University), Yao Shen(Hunan Normal University), Yixuan Gong(Memorial Sloan Kettering Cancer Center), John P. Sfakianos(Icahn School of Medicine at Mount Sinai), Alexander Kirschenbaum(Icahn School of Medicine at Mount Sinai), Michael Ohlmeyer(Princeton Satellite Systems (United States))
Cancer Research
January 22, 2018
Cited by 86


Related Papers